GPER1 and Other metabolic disease: Further research is necessary to elucidate the precise mechanisms by which GPR30 and the PI3K/Akt pathway interact to modulate the effects of an HFD and to determine how these pathways can be targeted for therapeutic interventions in metabolic disorders.